Ozenoxacin clinical trials
How each study uses ozenoxacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 11 Dec 2017 · XEPI · NDA 208945 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses ozenoxacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoCompletedPhase 3Ferrer Internacional S.A.NCT02090764Written as Ozenoxacin
- Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoCompletedPhase 3Ferrer Internacional S.A.NCT01397461Written as ozenoxacin 1% cream
- Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic LesionsCompletedPhase 2Ferrer Internacional S.A.NCT01005771Written as GF-001001-00
Codes
What other systems call ozenoxacin · ClinicalTrials.gg INT000094
- MeSH (NLM) C000592413ozenoxacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) V0LH498RFOOZENOXACINConfirmed FDA, NLM, Wikidata
- RxNorm 1994739One source FDA
- Wikidata Q17125399ozenoxacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90935OzenoxacinOne source FDA
- DrugBank DB12924One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000592413 | ozenoxacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | V0LH498RFO | OZENOXACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1994739 | — | One source FDA |
| Wikidata | Q17125399 | ozenoxacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90935 | Ozenoxacin | One source FDA |
| DrugBank | DB12924 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.